Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
2019 · New England Journal of Medicine · 2,479 citations
https://doi.org/10.1056/nejmoa1816047
J
Jing Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.5K
Papers
24.2K
Citations
66
h-index
446
i10-index
Jing Wang is an academic researcher from Guangzhou University of Chinese Medicine. The author has contributed to research in topics: RNA modifications and cancer & Pancreatic and Hepatic Oncology Research & Cancer, Hypoxia, and Metabolism. The author has an h-index of 66, co-authored 1253 publications.
ORCID: 0000-0001-7199-4784Papers by this author
worksLoss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer’s disease
2021 · Cell Death and Differentiation · 627 citations
https://doi.org/10.1038/s41418-020-00685-9
Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers
2018 · Cell Reports · 377 citations
https://doi.org/10.1016/j.celrep.2018.03.077
Systematic Analysis of Splice-Site-Creating Mutations in Cancer
2018 · Cell Reports · 248 citations
https://doi.org/10.1016/j.celrep.2018.03.052
Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial
2018 · Endoscopy · 216 citations
https://doi.org/10.1055/s-0043-124870
AIFM2 blocks ferroptosis independent of ubiquinol metabolism
2020 · Biochemical and Biophysical Research Communications · 216 citations
https://doi.org/10.1016/j.bbrc.2020.01.066
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat